Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 21(10): 3514-22, 2001 May.
Article in English | MEDLINE | ID: mdl-11313477

ABSTRACT

In the yeast Saccharomyces cerevisiae, a and alpha mating-type information is stored in transcriptionally silenced cassettes called HML and HMR. Silencing of these loci, maintained by the formation of a specialized type of heterochromatin, requires trans-acting proteins and cis-acting elements. Proteins required for silencing include the Sir2 NAD(+)-dependent deacetylase, Sir3, and Sir4. Factors that bind to the cis elements at HMR and HML and that are important for silencing include the origin recognition complex (ORC). Mutations of any of these Sir proteins or combinations of cis elements result in loss of silencing. SUM1-1 was previously identified as a dominant mutation that restores silencing to HMR in the absence of either the Sir proteins or some of the cis elements. We have investigated the novel mechanism whereby Sum1-1 causes Sir-independent silencing at HMR and present the following findings: Sum1-1 requires the Sir2 homolog, Hst1, for silencing and most probably requires the NAD(+)-dependent deacetylase activity of this protein. Sum1-1 interacts strongly with ORC, and this strong interaction is dependent on HMR DNA. Furthermore, ORC is required for Sum1-1-mediated silencing at HMR. These observations lead to a model for Sum1-1 silencing of HMR in which Sum1-1 is recruited to HMR by binding to ORC. Sum1-1, in turn, recruits Hst1. Hst1 then deacetylates histones or other chromatin-associated proteins to cause chromatin condensation and transcriptional silencing.


Subject(s)
Fungal Proteins/genetics , Histone Deacetylases , Nuclear Proteins/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Sirtuins , Gene Expression Regulation, Fungal , Repressor Proteins , Sirtuin 2 , Transcriptional Activation
2.
Proc Natl Acad Sci U S A ; 97(11): 5807-11, 2000 May 23.
Article in English | MEDLINE | ID: mdl-10811920

ABSTRACT

Homologs of the chromatin-bound yeast silent information regulator 2 (SIR2) protein are found in organisms from all biological kingdoms. SIR2 itself was originally discovered to influence mating-type control in haploid cells by locus-specific transcriptional silencing. Since then, SIR2 and its homologs have been suggested to play additional roles in suppression of recombination, chromosomal stability, metabolic regulation, meiosis, and aging. Considering the far-ranging nature of these functions, a major experimental goal has been to understand the molecular mechanism(s) by which this family of proteins acts. We report here that members of the SIR2 family catalyze an NAD-nicotinamide exchange reaction that requires the presence of acetylated lysines such as those found in the N termini of histones. Significantly, these enzymes also catalyze histone deacetylation in a reaction that absolutely requires NAD, thereby distinguishing them from previously characterized deacetylases. The enzymes are active on histone substrates that have been acetylated by both chromatin assembly-linked and transcription-related acetyltransferases. Contrary to a recent report, we find no evidence that these proteins ADP-ribosylate histones. Discovery of an intrinsic deacetylation activity for the conserved SIR2 family provides a mechanism for modifying histones and other proteins to regulate transcription and diverse biological processes.


Subject(s)
Fungal Proteins/physiology , Gene Silencing/physiology , Histone Deacetylases/physiology , Histones/metabolism , Protein Processing, Post-Translational , Saccharomyces cerevisiae/enzymology , Silent Information Regulator Proteins, Saccharomyces cerevisiae , Trans-Activators/physiology , Acetylation , Adenosine Diphosphate Ribose/metabolism , Animals , Chickens , Fungal Proteins/genetics , Histone Deacetylases/genetics , Histones/chemistry , Lysine/metabolism , Multigene Family , NAD/metabolism , Niacinamide/metabolism , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/genetics , Sirtuin 2 , Sirtuins , Trans-Activators/genetics
3.
Am J Drug Alcohol Abuse ; 5(2): 235-45, 1978.
Article in English | MEDLINE | ID: mdl-747177

ABSTRACT

In a controlled double-blind clinical study, 42 patients reported side effects and severity of side effects to naltrexone on three different first-day doses and maintenance dosage regimens. Initiating doses of 25, 100, and 150 mg were administered. The maintenance regimens involved 350 mg of naltrexone per week for 4 weeks with drug administration in Group A, five times weekly; in Group B, three times weekly; and in Group C, twice weekly. All three groups received identical doses for the last dosage administered each week. The first-day doses produced no significant quantitative difference in side effects. Overall, the three groups reported little difference in side effects. Nonetheless, the regimen with the least number of patients reporting side effects daily was that of Group B. In no case, regardless of dose or dosage regimen, did any patient have side effects of such a nature as to require termination of their participation in the study.


Subject(s)
Drug Administration Schedule , Heroin Dependence/drug therapy , Naloxone/analogs & derivatives , Naltrexone/adverse effects , Administration, Oral , Adolescent , Adult , Double-Blind Method , Humans , Male , Middle Aged , Naltrexone/administration & dosage , Placebos , Self-Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...